Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...
Cancer is classified as the uncontrollable growth of mutated cells. There are different types of cancers that correlate to ...
A group of runners will set off from York this weekend in support of an Army Major, from Catterick Garrison, who has been ...
Oncopeptides AB ( ($SE:ONCO) ) has issued an update. Oncopeptides AB announced the publication of three case reports in the Journal of Cancer ...
TOMORROW, I’ll stand at the funeral of a man who changed everything. Commander Rich Sutton MBE didn’t just fly Sea King ...
In the late-stage MajesTEC-3 trial, Tecvayli plus the subcutaneous formulation of J&J’s antibody drug Darzalex beat ...
In cancer patients, the health of the thymus—a key part of the body's immune system—is associated with the outcomes these ...
A research team at the Seville Biomedical Institute (IBis) has identified a new molecular mechanism that explains the high ...
Chemo-induced myelosuppression can affect patients’ ability to do daily tasks, and management varies by patient, treatment ...